Medtech Fundings for November 2013

Fundings for medical technology in November 2013 totaled $472 million, led by the $120 million IPO by Tandem Diabetes. Below is a list of the month’s top fundings:

Company funding Product/technology
Tandem Diabetes, Inc., has raised $120 million in an initial public offering according to the company Insulin pump, glucose monitoring and other diabetes products
Direct Flow Medical, Inc., has raised $50 million in a private round of funding from PDL BioPharma according to press reports Transcatheter aortic valve system used to treat aortic stenosis
TriVascular, Inc., has raised $40 million in a Series E round of funding according to the company Minimally invasive technologies for treatment of endovascular aneurysm
Solta Medical, Inc., has raised $40 million in a round of funding according to the company Medical aesthetics devices and other products
Palmaz Scientific has raised $26.31 million of a planned $30 million round of funding according to a regulatory filing Advanced metallurgical nanotechnologies for use in implants in neurology and orthopedics
Pixium Vision has raised €15 million ($20.27 million) in a Series A round of funding according to the company Retinal implants
Sensible Medical Innovations Ltd. has raised $20 million in a private funding from Boston Scientific Corporation according to the company Thoracic fluid status monitor

For the complete list of medtech fundings during November 2013, see link.

Leave a Reply

Your email address will not be published. Required fields are marked *

825,335 Spambots Blocked by Simple Comments

HTML tags are not allowed.